Liu Congcong, Chen Lin, Kong Dong, Lyu Fangfang, Luan Linlin, Yang Lijuan
Ward III, Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong, China.
Department of Nursing, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong, China.
J Vasc Access. 2022 Jan;23(1):57-66. doi: 10.1177/1129729820978124. Epub 2020 Dec 10.
Peripheral intravenous catheters (PVCs) are widely used vascular access devices for infusion therapy; however, they are associated with relatively high failure rates. This study aimed to identify the incidence, risk factors and medical costs of PVC-induced complications in adult hospitalised adult patients in China.
An observational, prospective study on 1069 patients lasting 5 months was conducted at a tertiary teaching hospital.
Infiltration ranked first among PVC complications with an incidence of 17.8%, followed by occlusion (10.8%) and phlebitis (10.5%). Most complications in phlebitis (88.4%) and infiltration (93.7%) were Grade 1. Catheters left in for over 96 h did not show a higher incidence of complications. Patients from the surgical department were more susceptible to infiltration, phlebitis and occlusion. The 26 gauge (Ga) catheters decreased the risk of phlebitis and occlusion, whereas 24Ga catheters increased infiltration rates. Infusing irritant drugs increased phlebitis and infiltration rates. The presence of comorbidities and non-use of needleless connectors were associated with occlusion. Compared with forearm insertion, the risk of occlusion nearly doubled with the dorsum of the hand insertion and the risk of infiltration tripled with antecubital fossa insertion. Medical treatment costs for PVC complications ranged from 0.3 to 140.0 CNY.
Infiltration is the most common PVC-related adverse event. Clinically-indicated instead of routine replacement of catheters is safe. More efforts are warranted to improve nurses' adherence to recent guidelines in terms of insertion site selection and needleless connector utilisation to reduce medical costs associated with catheter replacement.
外周静脉导管(PVC)是输液治疗中广泛使用的血管通路装置;然而,它们的失败率相对较高。本研究旨在确定中国成年住院患者中PVC引起的并发症的发生率、危险因素和医疗费用。
在一家三级教学医院对1069例患者进行了为期5个月的观察性前瞻性研究。
渗出在PVC并发症中排名第一,发生率为17.8%,其次是堵塞(10.8%)和静脉炎(10.5%)。静脉炎(88.4%)和渗出(93.7%)的大多数并发症为1级。留置导管超过96小时并未显示出更高的并发症发生率。外科患者更容易发生渗出、静脉炎和堵塞。26号(Ga)导管降低了静脉炎和堵塞的风险,而24Ga导管增加了渗出率。输注刺激性药物会增加静脉炎和渗出率。合并症的存在和未使用无针接头与堵塞有关。与前臂穿刺相比,手背穿刺堵塞的风险几乎增加一倍,肘前窝穿刺渗出的风险增加两倍。PVC并发症的医疗费用在0.3至140.0元人民币之间。
渗出是最常见的与PVC相关的不良事件。临床指征而非常规更换导管是安全的。需要做出更多努力,以提高护士在穿刺部位选择和无针接头使用方面对最新指南的依从性,以降低与导管更换相关的医疗费用。